Rapport Therapeutics Inc.... (RAPP)
NASDAQ: RAPP
· Real-Time Price · USD
28.92
0.38 (1.33%)
At close: Oct 06, 2025, 9:36 AM
Rapport Therapeutics Common Stock Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
Cash & Equivalents | 55.07M | 57.6M | 56.8M | 39.31M | 110.27M | 74.37M | 70.17M |
Short-Term Investments | 205.38M | 227.78M | 248.47M | 281.35M | 225.97M | 118.98M | 77.31M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.03M | 211K | 160K | 189K | 189K | 2.07M | 551K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 9.79M | 5.59M | 4.52M | 5.28M | 4.42M | 5.38M | 3.39M |
Total Current Assets | 270.24M | 290.97M | 309.8M | 325.94M | 340.67M | 198.73M | 150.87M |
Property-Plant & Equipment | 14.22M | 10.87M | 4.97M | 5.02M | 5.24M | 5.49M | 4M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 15.25M | 11.09M | 5.13M | 5.21M | 5.43M | 7.56M | 4.55M |
Total Assets | 285.5M | 302.05M | 314.93M | 331.14M | 346.1M | 206.29M | 155.42M |
Account Payables | 3.18M | 2.14M | 1.95M | 1.32M | 1.88M | 1.45M | 2.5M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 1.76M | 1.01M | 737K | 720K | 703K | 686K | 670K |
Other Current Liabilities | 3.8M | 1.09M | 2.97M | 4.34M | -703K | 358K | 1.74M |
Total Current Liabilities | 11.88M | 9.38M | 8.77M | 7.1M | 8.1M | 9.88M | 8.8M |
Long-Term Debt | 10.1M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 170.78M |
Total Long-Term Liabilities | 10.1M | 6.83M | 739K | 931K | 1.12M | 1.3M | 172.25M |
Total Liabilities | 21.98M | 16.22M | 9.51M | 8.03M | 9.21M | 11.18M | 181.06M |
Total Debt | 11.86M | 7.84M | 1.48M | 1.65M | 1.82M | 1.98M | 2.15M |
Book Value | 263.51M | 285.84M | 305.43M | 323.11M | 336.89M | 195.11M | -25.63M |
Book Value Per Share | 0.74 | 1.48 | 1.58 | 1.69 | 1.67 | 1.00 | -0.14 |
Common Stock | 37K | 37K | 37K | 36K | 36K | 36K | 4K |
Retained Earnings | -174.54M | -147.81M | -123.75M | -103.77M | -86.23M | -68.11M | -45.44M |
Comprehensive Income | -76K | -95K | -522K | 400K | -183K | -160K | 4K |
Shareholders Equity | 263.51M | 285.84M | 305.43M | 323.11M | 336.89M | 195.11M | -25.63M |
Total Investments | 205.38M | 227.78M | 248.47M | 281.35M | 225.97M | 118.98M | 77.31M |